Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal and vasculopathic subjects

Minerva Cardioangiologica

Volumn 46, Issue 12, 1998, Pages 471-475

  Ferlito, S ^a   Gallina, M ^a  

^a NONE

Author keywords

Arginine; Arteriosclerosis; E selectin; Endothelins; Nitric oxide

Indexed keywords

ARGININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; ENDOTHELIN 1; NITRIC OXIDE;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BIOSYNTHESIS; BLOOD LEVEL; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; VASCULAR ENDOTHELIUM;

ARGININE; CEREBROVASCULAR DISORDERS; CORONARY ARTERIOSCLEROSIS; E-SELECTIN; ENDOTHELINS; FEMALE; HUMANS; MIDDLE AGED; NITRIC OXIDE;

EID: 0032460243     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Nakamura T, Ohyama Y, Masuda H, Kurashina T, Saito Y, Kato T et al. Chronic blockade of nitric oxide synthesis increases urinary endothelin-1 excretion. J Hypertens 1997;15:373-81.
2. Thomas JE, Nemirovsky A, Jelman V, Giannotta SL. Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors. Neurosurgery 1997;40:1245-9.
3. Filep JG. Endogenous endothelin modulates blood pressure, plasma volume and albumin escape after systemic nitric oxide blockade. Hypertension 1997;30: 22-8.
4. Hwang S, Ballantyne CM, Sharret AR, Smith LC, Davis CE, Gotto AM et al. Circulating adhesion molecules VCAM-1, ICAM-1 and and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997;96:4219-25.
5. Davies MJ, Gordon H, Gearing AJH, Bigott R, Katz D, Kariakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9.
6. DeCaterina R, Libby P, Peng JB, Thannickal VJ, Gimbrone MA Jr, Shin WS et al. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-8.
7. Gutman W, Hollywood CA. Simple, rapid method for the determining nitrates and nitrites in fluids. Clin Chem 1992;38:2152.
8. Bellamy MF, Goodfellow J, Tweddei AC, Brownee M, Gorman ST, Ellis GR et al. Oral L-arginine improves exercise tolerance and flow-related endothelial dysfunction in microvascular angina. Circulation 1996;94:1-125 (Ab. 2478).
9. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation 1996;94:130-4.
10. Kuo L, Davis MJ, Cannon MS, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculalion: restoration of endothelium-dependent responses by L-arginine. Circ Res 1992;70:465-76.
11. Drexler H, Fischell TA, Pinto FJ, Chenzbraun A, Botas J, Cooke JP et al. Effect of L-arginine on coronary endothelial function in cardiac transplant patients: relation to vessel wall morphology. Circulation 1994;89: 1615-23.
12. Hirooka Y, Egashira K, Imaizumi T, Tagawa T, Kai H, Sugimachi M et al. Effects of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differ between the coronary and forearm vasculatures in humans. J Am Coll Cardiol 1994;24:948-55.
13. Tagawa H, Mohri M, Ichiki T, Egashira K. L-arginine attenuates tachicardia-induced myocardial ischemia in patients with extensive coronary artery disease. Circulation 1997;96:1-316 (Ab 1713).
14. Bode-Boger SM, Boger HR, Thiele W, Creutzig A, Alexander K, Frolich JC. L-arginine infusion therapy restores vascular NO production and improves the symptoms of intermittent claudication in patients with peripheral artery disease. Circulation 1997;96:1-419 (Ab 2343).
15. Mitani Y, Maruyama K, Sakurai M. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 1997;96:689-97.
16. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991;81:695-700.
17. Rector TS, Nank AJ, Millen KA, Tschumperlin LK, Sih R, Pillai K et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996;93:2135-41.
18. Imaizumi T, Hirooka Y, Masaki H, Harada S, Momohara M, Tagawa T et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992;20:511-7.
19. Creager MA, Gallagher SM, Girerd XJ, Dzau YJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-53.
20. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991;338:1546-50.
21. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997;95:1783-90.
22. Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J Am Coll Cardiol 1995;26:1054-61.
23. Bode-Boger SM, Boger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K et al. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994;87:303-10.
24. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994;89:2176-82.
25. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemo-attractant protein-1 in cultured human endothelial cells. Circ Res 1995;76:980-6.
26. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemo-attractant protein-1 in cultured human endothelial cells. Circ Res 1995;76:980-6.
27. Philis-Tsimikas A, Witztum JL. L-arginine may inhibit atherosclerosis through inhibition of LDL oxidation. Circulation 1995;92:1-422.
28. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992;90:1168-72.
29. Minor RL Jr, Myers PR, Guerra R Jr, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990;86:2109-16.
30. Hamon M, Vallet B, Bauter C, Wernert N, McFadden EP, Lablanche J et al. Long-lerm oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation 1994;90:1357-62.
31. Tarry WC, Makhoul RG. L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler Thromb 1994;14:938-43.
32. Bosmans JM, Vrints GI, Koch MM, Cromheeke KML. Arginine inhibits negative remodelling and intimal tickening after balloon angioplasty of rabbit carotid arteries. Circulation 1996;94:1-4 (Ab 23).
33. Smoulders RA, Stehouwer CDA, Olthof CG, van Kamp GJ, Teerlink T, de Yries PMJ et al. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 1994;87:37-43.
34. Ferlito S, Gallina M. Nitrite plasma levels in hypercholesterolemic coronaropathic and diabetic patients. Perfusion 1998;11:335-7.
35. Ferlito S, Gallina M, Catassi S, Bisicchia A, Di Salvo MM. Endothelin plasma levels in normolipemic and hypercholesterolemic arteriopathics before and after vasoactive and lipid-lowering treatment. Nutr Metab Cardiovasc Dis 1998;11:335-7.
36. Ferlito S, Gallina M. Nitrite plasma levels in acute and chronic coronary heart disease. Minerva Cardioangiol 1997;45:553-8.
37. Galvani M, Ottani F, Ferrini D, Puggioni R, Amboni P, Tamele L et al. Levels of soluble E-selectin are not a marker of the unstable coronary plaque in patients with ischemic heart disease. Circulation 1997;96:1-333 (Ab 1858).
38. Squadrito E, Saitta A, Altavilla D, Iuculano M, Canale P, Campo GM et al. Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction. Inflamm Res 1996;45:14-9.
39. Shyu KG, Chang H, Lin CC, Kuan P. Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome. Chest 1996;109:1627-30.